Predictors of treatment response to serotonin and noradrenaline reuptake inhibitors in fibromyalgia

Abstract

Increased values of certain clinical and metabolic parameters (BMI, fasting glucose, fasting insulin, HOMA‑IR) as well as the presence of psychiatric comorbidities could affect the response to treatment with SNRIs in the patients with FM.